SuperworthLemaitre Vascular profit margin LMAT
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- 25.0%
- Operating margin, 12 months
- 29.5%
- Net margin on a year earlier
- +4.9 pts
- Peer median
- 4.3%
Over the twelve months to Jun 30, 2026, Lemaitre Vascular kept 25.0% of its revenue as net profit, with an operating margin of 29.5% and a gross margin of 72.9%.
Five years earlier its net margin was 19.1%.
The median for 10 medical instruments and supplies stocks of a similar size is 4.3%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 23.1% | 27.2% | 71.5% |
| FY2024 | 20.0% | 23.8% | 68.6% |
| FY2023 | 15.6% | 19.0% | 65.7% |
| FY2022 | 12.8% | 16.6% | 64.9% |
| FY2021 | 17.4% | 23.6% | 65.7% |
| FY2020 | 16.4% | 22.3% | 65.4% |
| FY2019 | 15.3% | 18.1% | 68.1% |
| FY2018 | 21.7% | 26.7% | 70.0% |
| FY2017 | 17.0% | 20.9% | 70.1% |
| FY2016 | 11.9% | 18.3% | 70.6% |
| FY2015 | 9.9% | 14.7% | 69.1% |
| FY2014 | 5.5% | 8.9% | 68.1% |
| FY2013 | 5.0% | 7.0% | 69.9% |
| FY2012 | 4.5% | 7.5% | 72.0% |
| FY2011 | 3.7% | 6.4% | 69.7% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 25.0% | +4.9 pts | 29.5% | |
| Q1 FY26 | 24.3% | +4.4 pts | 28.5% | |
| Q4 FY25 | 23.1% | +3.1 pts | 27.2% | |
| Q3 FY25 | 22.1% | +2.7 pts | 25.7% | |
| Q2 FY25 | 20.1% | +1.8 pts | 23.3% | |
| Q1 FY25 | 20.0% | +3.0 pts | 23.4% | |
| Q4 FY24 | 20.0% | +4.5 pts | 23.8% | |
| Q3 FY24 | 19.4% | +4.7 pts | 23.3% | |
| Q2 FY24 | 18.3% | +4.1 pts | 22.2% | |
| Q1 FY24 | 17.0% | +4.8 pts | 20.4% | |
| Q4 FY23 | 15.6% | +2.8 pts | 19.0% | |
| Q3 FY23 | 14.7% | +1.5 pts | 18.0% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Lemaitre Vascular's size, closest first, today.
| Company | Profit margin |
|---|---|
| LMATLemaitre Vascular | 25.0% |
| INSPInspire Medical Systems | 15.0% |
| UFPTUFP Technologies | 11.4% |
| EYENational Vision | 2.5% |
| CDRECadre | 5.3% |
| BVSBioventus | 9.4% |
| ATRCAtriCure | 1.9% |
| WRBYWarby Parker | 0.8% |
| STAAStaar Surgical | 1.1% |
| IRMDIradimed | 26.7% |
| NVSTEnvista | 3.3% |
| Peer median | 4.3% |
Where Lemaitre Vascular ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Lemaitre Vascular
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.